ICU Medical Inc

ICU Medical's P/E ratio of 4,249.76 is grotesquely disconnected from reality, suggesting either a near-zero earnings base or a data anomaly that demands scrutiny before any serious analysis. With the stock trading at 48.3 RSI—perfectly centered between oversold and overbought—there's no obvious directional momentum, yet the astronomical valuation multiple indicates the market is pricing in either a turnaround narrative or accounting peculiarity rather than current profitability. The 7.8% short interest is modest enough that squeeze mechanics aren't a primary concern, and sitting below 52-week highs leaves room for upside if fundamentals improve. This setup screams "broken valuation model"—whether because earnings collapsed or reporting shifted—making it a name that requires forensic accounting review before drawing meaningful conclusions about whether it's cheap or legitimately troubled.